Drug Shortage Report for ZINECARD
Report ID | 123764 |
Drug Identification Number | 02153432 |
Brand name | ZINECARD |
Common or Proper name | ZINECARD |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DEXRAZOXANE |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25ML Vial |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-04 |
Estimated end date | 2021-02-26 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-25 |
Company comments | Current inventory is distributed under strict allocation. |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.